相关临床试验
47
8 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
1862
进行中（未招募）
2
4.3%
已完成
20
42.5%
Enrolling By Invitation
1
2.1%
尚未招募
5
10.6%
招募中
10
21.3%
Unknown
8
17.0%
撤回
1
2.1%
暂无批准数据
- Researchers from the University of Derby and Plymouth have initiated the UK's first anti-viral drug trial for long COVID, testing medication previously used only for hospitalized COVID-19 patients. - The £1.25m ERASE project involves 72 participants receiving intravenous anti-viral treatment over five days, aiming to address symptoms like fatigue, breathlessness, and brain fog affecting over 2 million UK residents. - Early participant Ryan Cawley reports significant improvement in symptoms after receiving the treatment, describing feeling "like I have been given a new pair of lungs" and experiencing an "upward trajectory to recovery."
- A major clinical trial investigating β-hydroxy β-methylbutyrate (HMB) as a potential treatment for liver cirrhosis has been launched across eight UK hospitals, supported by £500,000 from NIHR. - The BOOST study aims to evaluate HMB's effectiveness in improving physical function and quality of life for the 60,000 UK patients diagnosed with cirrhosis, a condition currently lacking direct treatment options. - The trial will recruit 124 cirrhosis patients who will receive either HMB or placebo for 12 weeks, with researchers measuring outcomes using the Liver Frailty Index and quality of life assessments.
